Skip to content

Altimmune ALT Interest Paid

Interest Paid at other companies

MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$2.71M-5.3%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$0
PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.16M0.0%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$6.08M-33.5%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$2.21M0.0%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$7.58M-6.8%

Other financials

Income statement

See full
Revenue$26.0K+420%
Operating income-$24.2M-11.1%
Net income-$22.6M-15.3%
EPS (diluted)-$0.18+30.8%

Balance sheet

See full
Cash & equivalents$97.6M+98.7%
Total debt$34.8M+14,092%
Total equity$284.0M+99.8%
Total assets$335.6M+113%

Cash flow

See full
Operating cash flow-$20.9M-24.4%
CapEx$21.0K
Free cash flow-$21.0M

Valuation

See full
Market cap$558.14M-2.1%
Enterprise value$495.27M-5.0%
P/S13,613.2×-24,380×

Profitability

See full
Operating margin-230,461%-82,087pp
Net margin-214,861%-76,057pp
FCF margin-17,806.8%-110,030pp

Returns & leverage

See full
Return on equity-42.7%-8.7pp
Debt / equity0.1×+0.1×
Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Altimmune's interest paid?
Altimmune (ALT) reported interest paid of $849K in Q1 2026.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.